ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Sep 22, 2015
Insider Transaction Report
Form 4
Titus Gary
Director
Transactions
- Award
Common Stock
2015-09-18+10,000→ 10,000 totalExercise: $0.00Exp: 2019-09-18→ Common Stock (10,000 underlying) - Award
Common Stock
2015-09-18+10,000→ 28,000 total
Footnotes (2)
- [F1]Reflects the receipt of a restricted stock unit. Each restricted stock unit represents a contingent right to receive one (1) share of Immunocellular Therapeutics, Ltd. common stock. The restricted stock unit are fully vested as of the grant date.
- [F2]Reflects the receipt of a restricted stock unit. Each restricted stock unit represents a contingent right to receive one (1) share of ImmunoCellular Therapeutics, Ltd. common stock. During the period from September 18, 2015 to September 18, 2019, the restricted stock unit may vest and become immediately exercisable if the average daily closing price of ImmunoCellular Therapeutics, Ltd. common stock on the NYSE MKT during any five (5) consecutive trading day period exceeds a closing $1.50 weighted average bid and ask price per share (as adjusted for any stock splits and the like).